https://www.selleckchem.com/pr....oducts/oss-128167.ht
In all, our data suggest that HOTAIR may be subtype-specific in AML-M2 patients, also HOTAIR regulates AML differentiation by C/EBPBβ/HOTAIR/miR-17-5p/p21 pathway. The findings of the present study provide a novel insight into the mechanism of lncRNA-mediated differentiation and indicate that HOTAIR may be a promising therapeutic target for leukaemia, especially for AML with M2 type. Abbreviation AML acute myeloid leukaemia; APL acute promyelocytic leukaemia; ATRA all-trans retinoic acid; CCK8 cell Counting Kit-8; CDKs cyclin-depende
Aimer
Commentaire
Partagez
